Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLA-SCREEN: Genotype-Guided Therapy to Prevent SCARs in Gout
NCT07369622Phase 4Not yet recruiting
- Sponsor
- Hai Phong University of Medicine and Pharmacy
- Start
- Jan 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of allopurinol, febuxostat in gout, hyperuricemia, sponsored by Hai Phong University of Medicine and Pharmacy. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
allopurinolfebuxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT07369622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07369622.